NewsBenzingaAbCellera Biologics nel terzo trimestre: EPS $(0,13) supera la stima di $(0,16), ricavi a 10,639 milioni di dollari superano la stima di 8,416 milioni di dollari AbCellera Biologics nel terzo trimestre: EPS $(0,13) supera la stima di $(0,16), ricavi a 10,639 milioni di dollari superano la stima di 8,416 milioni di dollari Benzinga 2026.11.09 21:11 (GMT+0) Open on Benzinga Other news What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday